Evidence check: AMH in the context of sleep

The evidence linking AMH (anti-Müllerian hormone) to sleep is weak and largely speculative. AMH is a well-established biomarker of ovarian reserve, primarily used in fertility assessment. While sleep deprivation and circadian disruption are known to affect reproductive hormones (e.g., LH, FSH, estradiol), direct, consistent associations with AMH levels have not been demonstrated in robust human studies. Existing research is limited to small observational cohorts or animal models, often with conflicting results. Consumer health tests that claim to interpret AMH in the context of sleep quality or patterns are not supported by current evidence. AMH should be interpreted by a fertility specialist, not as a sleep-related marker. General sleep hygiene remains important for overall endocrine health, but no specific AMH-based intervention is warranted. Evidence grade: unclear/mixed. Sources: none from provided context; general knowledge from reproductive endocrinology literature.